United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
The current United Therapeutics(UTHR) stock price is $499.97, with a market capitalization of 21.91B. The stock trades at a price-to-earnings (P/E) ratio of 18.44.
As of 2026-03-03, United Therapeutics(UTHR) stock has fluctuated between $490.74 and $515.00. The current price stands at $499.97, placing the stock +1.9% above today's low and -2.9% off the high.
United Therapeutics(UTHR) shares are trading with a volume of 293.31K, against a daily average of 484.95K.
In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $537.19 and a 52-week low of $266.98.
In the last year, United Therapeutics(UTHR) shares hit a 52-week high of $537.19 and a 52-week low of $266.98.
UTHR News
United Therapeutics Inc. (NASDAQ:UTHR) stock gained on Monday after it shared positive news regarding its drug ralinepag, which achieved a significant milestone...
The latest announcement is out from United Therapeutics ( (UTHR) ). On March 2, 2026, United Therapeutics reported that its pivotal phase 3 ADVANCE OUTCOMES tr...
United Therapeutics (UTHR) announced that its long-term pivotal phase 3 ADVANCE OUTCOMES study met its primary endpoint, with ralinepag reducing the risk of a c...
Analyst ratings
71%
of 14 ratingsMore UTHR News
MannKind (MNKD) is back in focus after partner United Therapeutics introduced a soft mist inhaler designed to compete with Tyvaso DPI, raising fresh questions a...
United Therapeutics unveiled its new Tresmi soft mist inhaler platform, designed to improve patient experience in pulmonary hypertension treatment. The company...
United Therapeutics Corp (NASDAQ:UTHR) reported better-than-expected earnings for the fourth quarter on Wednesday. The company posted quarterly earnings of $7....
On its earnings conference call earlier, United Therapeutics (UTHR) announced a “category killer product” called Tresmi, a “revolutionary proprietary drug devic...
(RTTNews) - United Therapeutics Corp (UTHR) released earnings for its fourth quarter that Increased, from last year The company's earnings came in at $364.3 mi...
Advertisement United Therapeutics stock: recent performance snapshot With no single headline event driving the move, United Therapeutics (UTHR) has drawn atte...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.